GlassScriptPhysician profile
Karol Gutowski
NPI 1134198799
$53,062.40
in general payments reported to CMS, 2019-2025
20 companies · $9,507 in 2025
The $9,507 reported for 2025 was more than what 95% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $7,583 · 2021: $981 · 2022: $5,060 · 2023: $86.16 · 2024: $320 · 2025: $9,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Food and Beverage: $711 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Food and Beverage | $711.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $201.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $37,210.75 | 2019-2023 | Xeomin |
| Integra Lifesciences Corporation | $9,011.03 | 2025 | Integra, Omnigraft, Surgimend |
| Surgical Innovation Associates, INC. | $2,586.82 | 2022 | |
| Abbvie INC. | $2,348.19 | 2022-2025 | |
| Covidien LP | $420.00 | 2019 | |
| Allergan, INC. | $377.28 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $226.66 | 2021 | |
| Bard Peripheral Vascular, INC. | $144.19 | 2021 | |
| Kerecis Limited | $137.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $130.64 | 2025 | |
| Tela Bio, INC. | $106.76 | 2024 | Ovitex 2s |
| Rti Surgical, INC | $83.33 | 2024 | |
| Galderma Laboratories, L.P. | $57.11 | 2019-2023 | |
| Medtronic, INC. | $50.00 | 2021 | |
| Sientra, INC. | $44.29 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $28.12 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Heron Therapeutics, INC. | $26.17 | 2022 | |
| Motiva USA, LLC | $25.55 | 2025 | |
| Boston Scientific Corporation | $24.08 | 2020 | |
| Tepha INC | $23.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karol Gutowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.